Linkage mapping of organizational DNA and sustainable performance through industry 4.0- enabled digital transformation: A cutting–edge PLS-SEM model analysis

Authors

  • Rawan Alshawabkeh Department of Business Administration, Business School, Al-Ahliyya Amman University, Jordan.
  • Amani Abu Rumman Department of Business Administration, Business School, Al-Ahliyya Amman University, Jordan.
  • Rowaida Al-Aqrabawi Department of Business Administration, Business School, Al-Ahliyya Amman University, Jordan.
  • Lina Al-Abbadi Department of Business Technology, Business School, Al-Ahliyya Amman University, Jordan.
  • Zeyad Alkhazali Department of Business Administration, Business School, Al-Ahliyya Amman University, Jordan.

DOI:

https://doi.org/10.18488/73.v13i4.4504

Abstract

This study was conducted to close the knowledge gap in previous research examining the effects of organizational DNA (ODNA) on sustainable performance (SP) through the mediating role of Industry 4.0 – Enabled Digital Transformation (I4.0-DT). The current study methodology is based on a mixed approach combining a systematic literature review with a self-reported questionnaire administered to the study sample.  The study used data gathered from senior and middle-level managers working in pharmaceutical manufacturing companies in Jordan. A random sample consisted of 300 managers.  SEM-PLS was used for analysis. The results show that ODNA enhances SP across economic, environmental, and social dimensions. The study identifies that I4.0– DT partially mediates the relationship between ODNA and SP interpreted as around 31.74% of the total effect. These findings highlight that while ODNA is critical; its effectiveness is multiplied by integrating advanced technologies. The implications of this study provide practical guidance for managers in the pharmaceutical sector. Pharmaceutical companies can leverage these findings to justify investments in I4.0-DT to enhance the impact of ODNA on SP. This can be achieved by cultivating a culture of continuous learning, innovation, and adaptability, improving the effectiveness of their digital transformation initiatives and thus achieving SP.

Keywords:

Digital transformation, Industry 4.0, Jordan, Organizational DNA, Pharmaceutical companies, Sustainable performance.

Downloads

Download data is not yet available.

Published

2025-10-30

Issue

Section

Articles